May 2026
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven by a simple but systemic hurdle: many healthcare professionals (HCPs) rarely encounter specific rare conditions in daily practice, and symptoms are often variable and non-specific, leading to missed signs and misdiagnoses. However, new research by Medscape presented at the World Orphan Drug Congress Europe 2025 suggests a powerful solution lies in precision targeted medical education.
In May 2026, Rare Diseases International convened a side event during the World Health Assembly in Geneva called, ‘Rare Diseases: a Catalyst for Global Health Transformation’. A key message was that we need to integrate rare diseases into everyday clinical practice and Universal Health Coverage.
How do we do that, and what is the role for Continuing Medical Education (CME)?
Diagnostic Acceleration and the Genomic Frontline
Speakers highlighted the rapid expansion in early diagnosis tools, from expanded newborn screening to AI algorithms capable of flagging genetic anomalies in electronic health records. Furthermore, nations such as Malaysia are increasingly anchoring rare diseases under the broader umbrella of precision medicine.
What does this mean for healthcare professional education? Physicians should no longer view genomics as a niche subspecialty. We must equip frontline providers with practical skills to integrate AI diagnostic tools, interpret genetic panels, and confidently navigate newborn screening. CME must focus on reducing the average diagnostic odyssey from years to months.
Shifting to Holistic Care Models
A recurring theme from international pioneers, such as France’s national rare disease strategy, is the transition from a purely biomedical focus to a comprehensive "care and life pathway." Rare diseases severely impact education, employment, mental health, and financial stability.
Thus, clinical training must move beyond symptom management. We need to train physicians in multidisciplinary case management. Clinicians must learn to connect families with social workers, psychological support, and community resources. Treating a patient with a rare disease means recognizing that their social needs are just as critical as their medical ones.
Navigating Regional Centers of Excellence
No single physician or country can manage the complexity of rare diseases alone. The success of European Reference Networks (ERNs) and emerging collaborations in the ASEAN region prove that pooling expertise is the only sustainable path forward.
Indeed, we cannot expect any physician to be an expert in 7,000+ rare diseases. Instead, education must train them on how to navigate the system. Clinicians need actionable guidance on referring patients to regional centers of excellence, incorporating cross-border diagnostic networks, and leveraging telehealth to consult with global specialists.
Partnering With Patients
The most striking takeaways from the side event came from patient advocates. Young patients managing complex conditions navigate medical and insurance systems with an expertise that rivals seasoned professionals. A young advocate from RDI’s Youth Leadership Program noted, patients do not want to be passively "waiting with hope"—they want to be active citizens shaping their care.
We must fundamentally rewrite how we teach patient communication. Physicians must be open to seeing patients and caregivers as experts of their own condition. Education must center on shared decision-making, respecting the patient’s lived experience, and incorporating patient-reported outcomes into standard evaluations.
The Path Forward
The GAPRD is more than a policy framework; it is a clinical curriculum for the future of medicine. At Medscape, our mandate is clear. We must build educational programs that empower physicians to be proactive navigators, genomic translators, and empathetic partners in care.